JPS60222470A - 1−カルボキシルアルキル−5−メルカプトテトラゾ−ルの製法 - Google Patents

1−カルボキシルアルキル−5−メルカプトテトラゾ−ルの製法

Info

Publication number
JPS60222470A
JPS60222470A JP60046700A JP4670085A JPS60222470A JP S60222470 A JPS60222470 A JP S60222470A JP 60046700 A JP60046700 A JP 60046700A JP 4670085 A JP4670085 A JP 4670085A JP S60222470 A JPS60222470 A JP S60222470A
Authority
JP
Japan
Prior art keywords
formula
mercaptotetrazole
solution
compound
thiol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60046700A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6348870B2 (de
Inventor
ウイリアム ジエイ ゴツトステイン
ムーレイ エイ カプラン
アルフオンス ピー グラナテツク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of JPS60222470A publication Critical patent/JPS60222470A/ja
Publication of JPS6348870B2 publication Critical patent/JPS6348870B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C265/00Derivatives of isocyanic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP60046700A 1974-09-03 1985-03-11 1−カルボキシルアルキル−5−メルカプトテトラゾ−ルの製法 Granted JPS60222470A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50299174A 1974-09-03 1974-09-03
US502991 1974-09-03
US590971 1990-10-01

Publications (2)

Publication Number Publication Date
JPS60222470A true JPS60222470A (ja) 1985-11-07
JPS6348870B2 JPS6348870B2 (de) 1988-09-30

Family

ID=24000311

Family Applications (2)

Application Number Title Priority Date Filing Date
JP60046699A Granted JPS60222489A (ja) 1974-09-03 1985-03-11 7−アミノセフエム化合物の製法
JP60046700A Granted JPS60222470A (ja) 1974-09-03 1985-03-11 1−カルボキシルアルキル−5−メルカプトテトラゾ−ルの製法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP60046699A Granted JPS60222489A (ja) 1974-09-03 1985-03-11 7−アミノセフエム化合物の製法

Country Status (14)

Country Link
JP (2) JPS60222489A (de)
AT (3) AT349140B (de)
AU (1) AU503240B2 (de)
BE (1) BE832725A (de)
BG (1) BG27753A3 (de)
CH (1) CH623330A5 (de)
CS (3) CS202056B2 (de)
CY (1) CY1120A (de)
GB (1) GB1525626A (de)
HK (1) HK45081A (de)
KE (1) KE3157A (de)
MY (1) MY8200111A (de)
SU (2) SU691094A3 (de)
ZA (1) ZA755543B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093723A (en) 1976-05-19 1978-06-06 Smithkline Corporation 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl) cephalosporins
US4082912A (en) 1976-06-30 1978-04-04 Bristol-Myers Company Certain 7-acylamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylmethyl)-3-cephem-4-carboxylic acids their salts and easily hydrolyzed esters
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid
US4278670A (en) * 1976-07-12 1981-07-14 Smithkline Corporation 7-Alpha-oxyiminoacylcephalosporins
US4117125A (en) 1977-06-24 1978-09-26 Smithkline Corporation 7-Acylamino-3-[1-[2-(carboxymethylamino]ethyl) tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
DK225179A (da) 1978-06-22 1979-12-23 Chugai Pharmaceutical Co Ltd Fremgangsmaade til fremstilling af cephalosporinderivater
JPH01300075A (ja) * 1988-05-25 1989-12-04 Tokyo Seimitsu Hatsujo Kk 流動体注入装置

Also Published As

Publication number Publication date
AU503240B2 (en) 1979-08-30
BG27753A3 (en) 1979-12-12
CH623330A5 (en) 1981-05-29
JPS6348870B2 (de) 1988-09-30
MY8200111A (en) 1982-12-31
CY1120A (en) 1981-12-04
CS202057B2 (en) 1980-12-31
BE832725A (fr) 1976-02-25
HK45081A (en) 1981-09-11
SU685157A3 (ru) 1979-09-05
ATA676475A (de) 1978-08-15
JPS60222489A (ja) 1985-11-07
CS202058B2 (en) 1980-12-31
JPS6135200B2 (de) 1986-08-12
ZA755543B (en) 1976-07-28
ATA723377A (de) 1978-07-15
SU691094A3 (ru) 1979-10-05
ATA294178A (de) 1978-09-15
GB1525626A (en) 1978-09-20
CS202056B2 (en) 1980-12-31
AU8446975A (en) 1977-03-10
KE3157A (en) 1981-09-18
AT349140B (de) 1979-03-26
AT349638B (de) 1979-04-10
AT348520B (de) 1979-02-26

Similar Documents

Publication Publication Date Title
JPH0631300B2 (ja) 結晶性アジスロマイシン2水和物及びその製法
TWI445697B (zh) 塔適那偉(atazanavir)硫酸氫鹽之製法及其新穎的形式
JPS60222470A (ja) 1−カルボキシルアルキル−5−メルカプトテトラゾ−ルの製法
JP2004527577A (ja) 4−フェニル酪酸の合成
JPH08506332A (ja) テトラゾール−5−カルボン酸誘導体の製法
KR20040111490A (ko) 새로운 형태의 n-(트랜스-4-이소프로필사이클로헥실카보닐)-d-페닐알라닌
CA1106850A (en) 8h-indeno ¬ 2,1-b| thiophen-2-oxaminic acids and esters thereof
JPS62155268A (ja) ナイザチジンの合成法
JPS59130856A (ja) 1−シアノ−3−(フルオルアルキル)グアニジン
KR100305484B1 (ko) 피페라지닐피리디닐수포접물
JPH0399084A (ja) マロンアミド誘導体金属錯体及び芳香族化合物用分離剤
JPH0149706B2 (de)
US2800485A (en) Method of making mono-
JPH05508633A (ja) デフェロキサミンの調製に用いる中間体
JP2685120B2 (ja) ジチアゾリウム塩の製造方法
JPH0631302B2 (ja) エトポシド−2−ジメチルアミノ体塩酸二水和結晶及びその製造法
JP2001261647A5 (de)
JPS5840541B2 (ja) 3− チカン −2( 1 h ) ピリドン −6− カルボンサンノ セイホウ
US4113948A (en) 1-amino-1-phthalidyl alkanes and a method for producing same
JP3230723B2 (ja) 2−(フルフリルチオ)酢酸誘導体の製造方法
JPH07196620A (ja) 8−オキシキノリン−アルミニウム塩の製造方法
JPH07103115B2 (ja) 2−(10,11−ジヒドロ−10−オキソジベンゾ〔b,f〕チエピン−2−イル)プロピオン酸の結晶化方法
JPH07504159A (ja) モリシジン塩酸塩の製造法
JPH02101037A (ja) 3−ヒドロキシ−4−フエニル−2−ブタノンの製法
JPS5921662A (ja) 結晶性dl―システィン